chrX-115189683-T-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2

The ENST00000317135.13(LRCH2):​c.350-1313A>C variant causes a intron change. The variant allele was found at a frequency of 0.000006 in 1,167,196 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000088 ( 0 hom., 0 hem., cov: 25)
Exomes 𝑓: 0.0000057 ( 0 hom. 2 hem. )

Consequence

LRCH2
ENST00000317135.13 intron

Scores

8
4
5

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.71
Variant links:
Genes affected
RBMXL3 (HGNC:26859): (RBMX like 3) Predicted to enable mRNA binding activity and snRNA binding activity. Predicted to be involved in mRNA splicing, via spliceosome. Predicted to be part of U12-type spliceosomal complex. [provided by Alliance of Genome Resources, Apr 2022]
LRCH2 (HGNC:29292): (leucine rich repeats and calponin homology domain containing 2) This gene encodes a member of the leucine-rich repeat and calponin homology domain-containing protein family. These family members contain multiple N-terminal leucine-rich repeats, in addition to a C-terminal calponin homology domain, a type of domain that mediates interactions with actin filaments. These proteins are conserved across animal species, and studies of a similar Drosophila protein indicate a function as a cytoskeletal scaffolding protein. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Sep 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.87
BS2
High Hemizygotes in GnomAdExome4 at 2 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RBMXL3NM_001145346.2 linkuse as main transcriptc.242T>G p.Val81Gly missense_variant 1/1 ENST00000424776.5 NP_001138818.1
LRCH2NM_020871.4 linkuse as main transcriptc.350-1313A>C intron_variant ENST00000317135.13 NP_065922.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RBMXL3ENST00000424776.5 linkuse as main transcriptc.242T>G p.Val81Gly missense_variant 1/1 NM_001145346.2 ENSP00000417451 P1
LRCH2ENST00000317135.13 linkuse as main transcriptc.350-1313A>C intron_variant 1 NM_020871.4 ENSP00000325091 P2Q5VUJ6-1
LRCH2ENST00000538422.2 linkuse as main transcriptc.350-1313A>C intron_variant 1 ENSP00000439366 A2Q5VUJ6-2

Frequencies

GnomAD3 genomes
AF:
0.00000884
AC:
1
AN:
113173
Hom.:
0
Cov.:
25
AF XY:
0.00
AC XY:
0
AN XY:
35313
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000569
AC:
6
AN:
1054023
Hom.:
0
Cov.:
33
AF XY:
0.00000580
AC XY:
2
AN XY:
344905
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000610
Gnomad4 OTH exome
AF:
0.0000225
GnomAD4 genome
AF:
0.00000884
AC:
1
AN:
113173
Hom.:
0
Cov.:
25
AF XY:
0.00
AC XY:
0
AN XY:
35313
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000188
Gnomad4 OTH
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 12, 2024The c.242T>G (p.V81G) alteration is located in exon 1 (coding exon 1) of the RBMXL3 gene. This alteration results from a T to G substitution at nucleotide position 242, causing the valine (V) at amino acid position 81 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.89
BayesDel_addAF
Pathogenic
0.32
D
BayesDel_noAF
Pathogenic
0.23
CADD
Benign
20
DANN
Uncertain
0.98
DEOGEN2
Benign
0.14
T
FATHMM_MKL
Benign
0.60
D
LIST_S2
Uncertain
0.90
D
M_CAP
Benign
0.022
T
MetaRNN
Pathogenic
0.87
D
MetaSVM
Uncertain
0.45
D
MutationAssessor
Pathogenic
3.6
H
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Benign
0.41
T
PROVEAN
Pathogenic
-5.6
D
REVEL
Uncertain
0.60
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.52
MutPred
0.73
Loss of stability (P = 0.0189);
MVP
0.12
ClinPred
0.96
D
GERP RS
0.68
Varity_R
0.56
gMVP
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2072766043; hg19: chrX-114424246; API